samedan logo

 
 
spacer
home > ict > winter 2019 > specialist shortage
PUBLICATIONS
International Clinical Trials

Specialist Shortage

The clinical research associate (CRA) or clinical trial monitor is an essential role in drug development. This role is involved across all phases of clinical trials and carries out tasks such as trial site set-up, initiation, monitoring, and close-down. It is known for offering good remuneration packages and flexible working patterns and is a pathway into the clinical trials world.

For a number of years, a trend within the pharmaceutical industry has been to outsource part, or all, of their key activities, from early- to late-stage trials, patient recruitment, clinical data management, IT, central laboratory services, regulatory, biostatistics, and clinical trial supplies. Within clinical operations, the outsourcing of monitoring has meant that, increasingly, CRAs are employed by CROs rather than with a sponsor or pharma company. In turn, this operating model has increased the need within CROs to recruit experienced CRAs to support their business and help deliver their trials successfully.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Steve Lord has been a Principal Consultant at CK Clinical for the past two years and has 20 years of recruitment experience.
spacer
Steve Lord
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

CPhI China opens with analysis pointing to a surge in growth in 2019

Shanghai, 23rd May 2019: New analysis released ahead of CPhI & P-MEC China (#CPhIChina and #PMECChina) – co-organized by Informa Markets, CCCMHPIE, and Shanghai Sinoexpo Informa Markets – forecasts that China will continue to grow strongly through 2019/20, thanks in part to a marked improvement in its global reputation.
More info >>

White Papers

Delivering Fit For Purpose Biomanufacturing CHO Cell Lines

Fujifilm Diosynth Biotechnologies

The challenge during mammalian cell line development is to identify and isolate stable, high expressing cell lines producing product with the appropriate critical product quality attributes rapidly, reproducibly and with relative ease. Obtaining a host cell line that inherently exhibits desirable biomanufacturing attributes can therefore have a significantly positive effect on the identification of recombinant cell lines with desired traits during cell line development screens. In this study, we demonstrate that it is possible to exploit intrinsic heterogeneity within host cell populations and identify host cell lines which are more “fit for purpose”.
More info >>

 
Industry Events

2020 Avoca Quality and Innovation Summit

3-4 June 2020, Amsterdam, The Netherlands

The 2020 Avoca Quality and Innovation Summit will take place 3-4 June 2020, in Amsterdam, The Netherlands.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement